Screening for CD19-specific chimaeric antigen receptors with enhanced signalling via a barcoded library of intracellular domains
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Screening for CD19-specific chimaeric antigen receptors with enhanced signalling via a barcoded library of intracellular domains
Authors
Keywords
-
Journal
Nature Biomedical Engineering
Volume 6, Issue 7, Pages 855-866
Publisher
Springer Science and Business Media LLC
Online
2022-06-17
DOI
10.1038/s41551-022-00896-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A chimeric antigen receptor with antigen-independent OX40 signaling mediates potent antitumor activity
- (2021) Huihui Zhang et al. Science Translational Medicine
- IFNg is Critical for CAR T Cell Mediated Myeloid Activation and Induction of Endogenous Immunity
- (2021) Darya Alizadeh et al. Cancer Discovery
- The therapeutic landscape for cells engineered with chimeric antigen receptors
- (2020) Matthew MacKay et al. NATURE BIOTECHNOLOGY
- Human chimeric antigen receptor macrophages for cancer immunotherapy
- (2020) Michael Klichinsky et al. NATURE BIOTECHNOLOGY
- 4-1BB costimulation promotes CAR T cell survival through noncanonical NF-κB signaling
- (2020) Benjamin I. Philipson et al. Science Signaling
- GPC1 specific CAR-T cells eradicate established solid tumor without adverse effects and synergize with anti-PD-1 Ab
- (2020) Daiki Kato et al. eLife
- Chimeric antigen receptor signaling: Functional consequences and design implications
- (2020) S. E. Lindner et al. Science Advances
- Multiple Signaling Roles of CD3ε and Its Application in CAR-T Cell Therapy
- (2020) Wei Wu et al. CELL
- A Distinct Transcriptional Program in Human CAR T Cells Bearing the 4-1BB Signaling Domain Revealed by scRNA-Seq
- (2020) Angela C. Boroughs et al. MOLECULAR THERAPY
- Noncanonical binding of Lck to CD3ε promotes TCR signaling and CAR function
- (2020) Frederike A. Hartl et al. NATURE IMMUNOLOGY
- T Cells Expressing NKG2D CAR with a DAP12 Signaling Domain Stimulate Lower Cytokine Production While Effective in Tumor Eradication
- (2020) Yu-Yang Ng et al. MOLECULAR THERAPY
- BATF3 programs CD8+ T cell memory
- (2020) Marco A. Ataide et al. NATURE IMMUNOLOGY
- Characteristics of anti-CD19 CAR T cell infusion products associated with efficacy and toxicity in patients with large B cell lymphomas
- (2020) Qing Deng et al. NATURE MEDICINE
- Next-generation cell therapies: the emerging role of CAR-NK cells
- (2020) Rafet Basar et al. Hematology-American Society of Hematology Education Program
- Comprehensive Integration of Single-Cell Data
- (2019) Tim Stuart et al. CELL
- Clinical lessons learned from the first leg of the CAR T cell journey
- (2019) Robbie G. Majzner et al. NATURE MEDICINE
- Determinants of response and resistance to CAR T cell therapy
- (2019) Stefanie Lesch et al. SEMINARS IN CANCER BIOLOGY
- Preclinical Models in Chimeric Antigen Receptor–Engineered T-Cell Therapy
- (2018) Elizabeth Louise Siegler et al. HUMAN GENE THERAPY
- Understanding the tumor immune microenvironment (TIME) for effective therapy
- (2018) Mikhail Binnewies et al. NATURE MEDICINE
- A novel chimeric antigen receptor containing a JAK–STAT signaling domain mediates superior antitumor effects
- (2018) Yuki Kagoya et al. NATURE MEDICINE
- CAR-T cells: the long and winding road to solid tumors
- (2018) Maria Michela D’Aloia et al. Cell Death & Disease
- Cytokine release syndrome
- (2018) Alexander Shimabukuro-Vornhagen et al. Journal for ImmunoTherapy of Cancer
- Strategies to Address Chimeric Antigen Receptor Tonic Signaling
- (2018) Adam Ajina et al. MOLECULAR CANCER THERAPEUTICS
- Dysfunctional CD8 T Cells Form a Proliferative, Dynamically Regulated Compartment within Human Melanoma
- (2018) Hanjie Li et al. CELL
- Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma
- (2018) Moshe Sade-Feldman et al. CELL
- Calibration of CAR activation potential directs alternative T cell fates and therapeutic potency
- (2018) Judith Feucht et al. NATURE MEDICINE
- Expansion and Activation of CD103 + Dendritic Cell Progenitors at the Tumor Site Enhances Tumor Responses to Therapeutic PD-L1 and BRAF Inhibition
- (2016) Hélène Salmon et al. IMMUNITY
- Chimeric antigen receptor T-cell therapy for solid tumors
- (2016) Kheng Newick et al. Molecular Therapy-Oncolytics
- Structural Design of Engineered Costimulation Determines Tumor Rejection Kinetics and Persistence of CAR T Cells
- (2015) Zeguo Zhao et al. CANCER CELL
- DAP12-Based Activating Chimeric Antigen Receptor for NK Cell Tumor Immunotherapy
- (2015) Katrin Töpfer et al. JOURNAL OF IMMUNOLOGY
- Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity
- (2015) Stefani Spranger et al. NATURE
- 4-1BB costimulation ameliorates T cell exhaustion induced by tonic signaling of chimeric antigen receptors
- (2015) Adrienne H Long et al. NATURE MEDICINE
- Generation of Potent T-cell Immunotherapy for Cancer Using DAP12-Based, Multichain, Chimeric Immunoreceptors
- (2015) E. Wang et al. Cancer Immunology Research
- GSVA: gene set variation analysis for microarray and RNA-Seq data
- (2013) Sonja Hänzelmann et al. BMC BIOINFORMATICS
- A Cell-Intrinsic Requirement for NF- B-Inducing Kinase in CD4 and CD8 T Cell Memory
- (2013) A. M. Rowe et al. JOURNAL OF IMMUNOLOGY
- Engineering T Cell Function Using Chimeric Antigen Receptors Identified Using a DNA Library Approach
- (2013) Connie P. M. Duong et al. PLoS One
- OX40 costimulation by a chimeric antigen receptor abrogates CD28 and IL-2 induced IL-10 secretion by redirected CD4+T cells
- (2012) Andreas A. Hombach et al. OncoImmunology
- Costimulation by chimeric antigen receptors revisited the T cell antitumor response benefits from combined CD28-OX40 signalling
- (2011) Andreas A. Hombach et al. INTERNATIONAL JOURNAL OF CANCER
- Differentiation and Persistence of Memory CD8+ T Cells Depend on T Cell Factor 1
- (2010) Xinyuan Zhou et al. IMMUNITY
- Chimeric Antigen Receptors Combining 4-1BB and CD28 Signaling Domains Augment PI3kinase/AKT/Bcl-XL Activation and CD8+ T Cell–mediated Tumor Eradication
- (2009) Xiao-Song Zhong et al. MOLECULAR THERAPY
- Comparison of T Cell Receptor-Induced Proximal Signaling and Downstream Functions in Immortalized and Primary T Cells
- (2009) Rebekah R. Bartelt et al. PLoS One
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started